Patent · US Expired

Method for treating diabetes employing an aP2 inhibitor and combination

US7390824B1 · kind B1 · utility

8Cited by

12References

8Claims

0Family size

Assignees

Bristol-Myers Squibb Company · US
President and Fellows of Harvard College · US

Inventors

Jeffrey A. Robl · Newtown, US
Rex A. Parker · Titusville, US
Scott A. Biller · Hopewell, US
Haris Jamil · Newtown, US
Bruce L. Jacobson · Carlsbad, US
Krishna Kodukula · Princeton, US

Key dates

Filing date	Sep 7, 1999
Grant date	Jun 24, 2008
Priority date	—
Expiry date	Dec 29, 2021

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K31/425
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A method is provided for treating diabetes and related diseases, especially Type II diabetes, employing an aP2 inhibitor or a combination of an aP2 inhibitor and another antidiabetic agent such as metformin, glyburide, troglitazone and/or insulin.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.